64 related articles for article (PubMed ID: 2657275)
1. In vitro/in vivo functionality of Catapres-TTS.
Enscore DJ; Osborne JL; Shaw JE
Methods Find Exp Clin Pharmacol; 1989 Mar; 11(3):173-8. PubMed ID: 2657275
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo characterization of a newly developed clonidine transdermal patch for treatment of attention deficit hyperactivity disorder in children.
Ke GM; Wang L; Xue HY; Lu WL; Zhang X; Zhang Q; Guo HY
Biol Pharm Bull; 2005 Feb; 28(2):305-10. PubMed ID: 15684489
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of nitroglycerin and clonidine delivered by the transdermal route.
Shaw JE
Am Heart J; 1984 Jul; 108(1):217-23. PubMed ID: 6428208
[TBL] [Abstract][Full Text] [Related]
4. Transdermal clonidine (Catapres-TTS) monotherapy in the management of mild hypertension in general practice.
Lewis GR
N Z Med J; 1987 Nov; 100(836):711-3. PubMed ID: 3330602
[TBL] [Abstract][Full Text] [Related]
5. A community-based trial of transdermal antihypertensive therapy with clonidine (Catapres-TTS).
Kellaway GS; Lubbe WF
N Z Med J; 1986 Sep; 99(810):711-4. PubMed ID: 3547202
[TBL] [Abstract][Full Text] [Related]
6. [Transdermal therapy of arterial hypertension: a new approach in the management of hypertensive patients].
Ambrosioni E
Ann Ital Med Int; 1994 Oct; 9 Suppl():54S-57S. PubMed ID: 7857759
[TBL] [Abstract][Full Text] [Related]
7. [Clonidine transdermal therapeutic system in essential hypertension: effect and tolerance].
Groth H; Vetter H; Knüsel J; Boerlin HJ; Walger P; Baumgart P; Wehling M; Siegenthaler W; Vetter W
Schweiz Med Wochenschr; 1983 Dec; 113(49):1841-5. PubMed ID: 6676936
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the pharmacokinetics, pharmacodynamics, and safety of oral (Catapres) and transdermal (M-5041T) clonidine in healthy subjects.
Fujimura A; Ebihara A; Ohashi K; Shiga T; Kumagai Y; Nakashima H; Kotegawa T
J Clin Pharmacol; 1994 Mar; 34(3):260-5. PubMed ID: 8021335
[TBL] [Abstract][Full Text] [Related]
9. Clonidine through the skin in the treatment of essential hypertension: is it practical?
Groth H; Vetter H; Knüsel J; Boerlin HJ; Walger P; Baumgart P; Wehling M; Siegenthaler W; Vetter W
J Hypertens Suppl; 1983 Dec; 1(2):120-2. PubMed ID: 6599488
[TBL] [Abstract][Full Text] [Related]
10. Patient acceptance of transdermal clonidine. A retrospective review of 25 patients.
Chen SW; Vidt DG
Cleve Clin J Med; 1989; 56(1):21-6. PubMed ID: 2731324
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and pharmacodynamics of transdermally administered clonidine.
Arndts D; Arndts K
Eur J Clin Pharmacol; 1984; 26(1):79-85. PubMed ID: 6714294
[TBL] [Abstract][Full Text] [Related]
12. Transdermal drug delivery: a review of pharmaceutics, pharmacokinetics, and pharmacodynamics.
Moore L; Chien YW
Crit Rev Ther Drug Carrier Syst; 1988; 4(4):285-349. PubMed ID: 3133121
[TBL] [Abstract][Full Text] [Related]
13. Treatment of hypertension by a new transdermal form of clonidine.
Gosse P; Wicker P; Roudaut R; Danays T; Dallocchio M
J Hypertens Suppl; 1985 Dec; 3(4):S65-7. PubMed ID: 3868714
[TBL] [Abstract][Full Text] [Related]
14. Transdermal therapeutic systems and rate controlled drug delivery.
Yum SI
Med Prog Technol; 1989; 15(1-2):47-52. PubMed ID: 2530425
[TBL] [Abstract][Full Text] [Related]
15. Innovative drug delivery systems in cardiovascular medicine: nifedipine-GITS and clonidine-TTS.
Frishman WH; Sherman D; Feinfeld DA
Cardiol Clin; 1987 Nov; 5(4):703-16. PubMed ID: 3331321
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of oral sustained release clonidine in humans.
MacGregor TR; Relihan GL; Keirns JJ
Arzneimittelforschung; 1985; 35(1A):440-6. PubMed ID: 4039184
[TBL] [Abstract][Full Text] [Related]
17. Use of transdermal clonidine in chronic hemodialysis patients.
Rosansky SJ; Johnson KL; McConnell J
Clin Nephrol; 1993 Jan; 39(1):32-6. PubMed ID: 8428405
[TBL] [Abstract][Full Text] [Related]
18. Clinical pharmacokinetics of clonidine.
Lowenthal DT; Matzek KM; MacGregor TR
Clin Pharmacokinet; 1988 May; 14(5):287-310. PubMed ID: 3293868
[TBL] [Abstract][Full Text] [Related]
19. Transdermal clonidine. A preliminary review of its pharmacodynamic properties and therapeutic efficacy.
Langley MS; Heel RC
Drugs; 1988 Feb; 35(2):123-42. PubMed ID: 3281820
[TBL] [Abstract][Full Text] [Related]
20. Rate and extent of absorption of clonidine from a transdermal therapeutic system.
Toon S; Hopkins KJ; Aarons L; Rowland M
J Pharm Pharmacol; 1989 Jan; 41(1):17-21. PubMed ID: 2565958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
